Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein(a) levels by more than 90% for at least six months with a single injection in a phase 2 trial, reinforcing its ...

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...

Welcome to New Music Friday, your ultimate round-up of this week's single, album and home entertainment releases. Let's kick off with this week's big new albums. Well, Robbie Williams dropped an ...

Abstract: Influence maximization in social networks has become a popular research area, aiming to identify the best set of nodes to spread information or influence within a network. Traditional ...

Abstract: Holographic Multiple-Input Multiple-Output (HMIMO), which densely integrates numerous antennas into a limited space, is anticipated to provide higher rates for future 6G wireless ...